Usefulness of Cell-Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment Efficacy.

doi:10.1002/hep4.1762

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Usefulness of Cell-Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment Efficacy.

Hepatology communications - 1 Nov 2021

Muraoka Masaru, Maekawa Shinya, Katoh Ryo, Komiyama Yasuyuki, Nakakuki Natsuko, Takada Hitomi, Matsuda Shuya, Suzuki Yuichiro, Sato Mitsuaki, Tatsumi Akihisa, Miura Mika, Amemiya Fumitake, Shindo Hiroko, Takano Shinichi, Fukasawa Mitsuharu, Yamauchi Kozue, Yamaguchi Tatsuya, Nakayama Yasuhiro, Inoue Taisuke, Enomoto Nobuyuki

Abstract excerpt

Although the usefulness of liquid biopsy as a biomarker in the treatment of hepatocellular carcinoma (HCC) has been suggested, its usefulness in transcatheter arterial chemoembolization (TACE) or tyrosine kinase inhibitor (TKI) therapies has not been reported in detail. In this study, we investigated the clinical value of a cell-free (cf)DNA quantification system targeting the human telomerase reverse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Hepatocellular

Share to Cell-Free Nucleic Acids

Share to Enzyme Inhibitors

Share to Liver Neoplasms

Share to Predictive Value of Tests

Share to Protein-Tyrosine Kinases

Share to Telomerase

Source

Open in PubMed Open full text

Identifiers

PMID: 34558819
DOI: 10.1002/hep4.1762
PMCID: PMC8557313

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Usefulness of Cell-Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment Efficacy.PMID 34558819Read ↗

Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients’ Management and Therapy OutcomesSemantic proximity Read ↗

Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.Semantic proximity Read ↗

Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and OutlookSemantic proximity Read ↗

Circulating tumor DNA mutation analysis: advances in its application for early diagnosis of hepatocellular carcinoma and therapeutic efficacy monitoring.Semantic proximity Read ↗

Circulating Tumor DNA Analysis for Liver Cancers and Its Usefulness as a Liquid BiopsySemantic proximity Read ↗

Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study.Semantic proximity Read ↗

Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients.Semantic proximity Read ↗

Circulating Tumor DNA and Hepatocellular CarcinomaSemantic proximity Read ↗

Using cell-free DNA for HCC surveillance and prognosisSemantic proximity Read ↗

Detection of a novel panel of somatic mutations in plasma cell-free DNA and its diagnostic value in hepatocellular carcinomaSemantic proximity Read ↗

Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?Semantic proximity Read ↗

Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.